GoodRx stock price, funding rounds, valuation and financials

GoodRx has raised $1.5 m in total funding. GoodRx annual revenue was $388.22 m in FY 2019

$123.3 M

GoodRx Revenue Q2, 2020
GoodRx Gross profit (Q2, 2020)116.5 M
GoodRx Gross profit margin (Q2, 2020), %94.5%
GoodRx Net income (Q2, 2020)27.3 M
GoodRx EBIT (Q2, 2020)41.7 M
GoodRx Cash, 30-Jun-2020126.6 M
Get notified regarding key financial metrics and revenue changes at GoodRxLearn more
Banner background

GoodRx Revenue

GoodRx revenue was $388.22 m in FY, 2019 which is a 55.6% year over year increase from the previous period.

Embed Graph

GoodRx Funding

Summary Metrics

Founding Date

2011

GoodRx total Funding

$1.5 m

Time since last funding

3 years ago

GoodRx investors

GoodRx Capital Raised

Embed Graph

GoodRx Revenue Breakdown

Embed Graph

GoodRx revenue breakdown by business segment: 93.9% from Prescription Transactions Revenue and 6.1% from Other

GoodRx Income Statement

Annual

USDFY, 2018FY, 2019

Revenue

249.5m388.2m

Revenue growth, %

56%

Cost of goods sold

6.0m14.0m

Gross profit

243.5m374.2m

Gross profit Margin, %

98%96%

Sales and marketing expense

104.2m177.0m

R&D expense

43.9m29.3m

General and administrative expense

8.4m14.7m

Operating expense total

166.2m234.5m

Depreciation and amortization

9.8m13.6m

EBIT

77.3m139.7m

EBIT margin, %

31%36%

Interest expense

22.2m49.6m

Interest income

154.0k715.0k

Pre tax profit

52.3m83.0m

Income tax expense

8.6m16.9m

Net Income

43.8m66.0m

EPS

0.10.2

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q4, 2019Q1, 2020Q2, 2020

Revenue

81.7m91.5m101.7m113.3m133.4m123.3m

Cost of goods sold

2.9m3.1m3.4m4.6m6.0m6.8m

Gross profit

78.8m88.4m98.3m108.7m127.4m116.5m

Gross profit Margin, %

96%97%97%96%95%94%

Sales and marketing expense

39.9m37.8m45.0m54.3m63.2m51.9m

R&D expense

5.6m6.0m7.8m9.8m10.3m12.0m

General and administrative expense

2.6m3.4m4.1m4.5m5.9m6.3m

Operating expense total

50.8m50.3m60.5m72.9m83.7m74.7m

Depreciation and amortization

2.6m3.1m3.6m4.2m4.3m4.5m

EBIT

28.0m38.1m37.8m35.8m43.7m41.7m

EBIT margin, %

34%42%37%32%33%34%

Interest expense

13.4m13.3m12.8m10.1m8.6m6.8m

Interest income

129.0k180.0k271.0k135.0k75.0k41.0k

Pre tax profit

14.7m25.0m25.3m17.9m35.1m35.0m

Income tax expense

3.2m5.3m5.7m2.7m7.8m7.7m

Net Income

11.6m19.7m19.6m15.2m27.3m27.3m

GoodRx Balance Sheet

Annual

USDFY, 2018FY, 2019

Cash

34.6m26.1m

Accounts Receivable

33.4m48.1m

Prepaid Expenses

5.1m12.4m

Current Assets

73.1m86.6m

PP&E

988.0k1.9m

Goodwill

220.4m236.2m

Total Assets

314.8m386.8m

Accounts Payable

7.2m7.9m

Short-term debt

5.4m10.0m

Current Liabilities

16.6m33.4m

Long-term debt

716.8m701.0m

Total Debt

722.2m711.0m

Total Liabilities

740.2m737.4m

Common Stock

451.0k460.0k

Preferred Stock

737.0m737.0m

Additional Paid-in Capital

8.8m

Retained Earnings

(1.2b)(1.1b)

Total Equity

(1.2b)(1.1b)

Debt to Equity Ratio

-0.6 x-0.7 x

Debt to Assets Ratio

2.3 x1.8 x

Financial Leverage

-0.3 x-0.4 x

Quarterly

USDQ2, 2020

Cash

126.6m

Accounts Receivable

58.8m

Prepaid Expenses

15.0m

Current Assets

200.4m

PP&E

5.2m

Goodwill

236.2m

Total Assets

502.4m

Accounts Payable

8.6m

Short-term debt

10.3m

Current Liabilities

60.0m

Long-term debt

726.0m

Total Debt

736.3m

Total Liabilities

792.2m

Common Stock

462.0k

Preferred Stock

737.0m

Additional Paid-in Capital

15.0m

Retained Earnings

(1.0b)

Total Equity

(1.0b)

Debt to Equity Ratio

-0.7 x

Debt to Assets Ratio

1.5 x

Financial Leverage

-0.5 x

GoodRx Cash Flow

Annual

USDFY, 2018FY, 2019

Net Income

43.8m66.0m

Depreciation and Amortization

9.8m13.6m

Accounts Receivable

(12.8m)(14.5m)

Accounts Payable

665.0k515.0k

Cash From Operating Activities

45.3m83.3m

Purchases of PP&E

(804.0k)(1.4m)

Cash From Investing Activities

(3.5m)(37.1m)

Long-term Borrowings

(294.9m)(211.8m)

Dividends Paid

(1.3b)

Cash From Financing Activities

(24.7m)(54.8m)

Net Change in Cash

17.1m(8.5m)

Interest Paid

18.7m48.4m

Income Taxes Paid

11.7m19.4m

Quarterly

USDQ2, 2019Q2, 2020

Net Income

31.2m54.7m

Depreciation and Amortization

5.7m8.9m

Accounts Receivable

(4.6m)(10.7m)

Accounts Payable

5.3m753.0k

Cash From Operating Activities

50.3m83.8m

Purchases of PP&E

(670.0k)(1.8m)

Cash From Investing Activities

(15.3m)(8.3m)

Long-term Borrowings

(8.7m)(3.5m)

Cash From Financing Activities

(6.8m)25.1m

Net Change in Cash

28.1m100.6m

Interest Paid

26.1m13.8m

Income Taxes Paid

318.0k1.5m

GoodRx Ratios

USDFY, 2018

Debt/Equity

-0.6 x

Debt/Assets

2.3 x

Financial Leverage

-0.3 x

GoodRx Employee Rating

4.683 votes
Culture & Values
4.7
Work/Life Balance
4.6
Senior Management
4.6
Salary & Benefits
4.6
Career Opportunities
4.6
Source